February 13, 2025 — IOI Corporation Berhad (IOI), through our German subsidiary KetoLipix Therapeutics GmbH (KetoLipix), is leading pharmaceutical innovation by developing drug therapies for conditions with high unmet medical need, leveraging KetoLipix’s breakthrough ketone ester technology.

You might also be interested in reading Crypto Market Maker Portofino Technologies Has Big Plans For 2025.